Researchers should prepare an abstract not exceeding 350 words including titles. The abstract should have a title, name(s) of author(s), author(s) affiliation(s), a maximum of five (5) keywords, and contacts (email address) of the corresponding author.
Researchers should select a track for their abstract and choose one option during the submission process
Option 1- The option is suited for research already conducted in all disciplines
Option 2 -The option is suited for lessons learned through programmatic, routine or project implementation or management
All submitted abstracts will go through a blind peer-review process carried out by a team of experts in the field of research. Reviewers will be required to sign Confidentiality Agreement Forms to ensure confidentiality in the review process
Track 1: Advancing COVID-19 clinical and biomedical research for improved health outcomes
Track 2: COVID-19 Epidemiology: Transmission Dynamics, Prevention, Vaccines and Outcomes
Track 3: COVID-19 and other health conditions: Impact and Interventions (e.g., non-communicable and communicable diseases)
Track 4: Impact of the pandemic and response: Health systems, psychosocial, social, economic, and cultural rights
All full abstract submissions will be peer reviewed and evaluated based on originality, technical and/or research content/depth, correctness, relevance to conference, contributions, and readability. English is the official language of the conference. We welcome abstract submissions. Prospective authors are invited to submit full (and original research) papers (which is NOT submitted or published or under consideration anywhere in other conferences/journal) in electronic (DOC or PDF) format.